Systematic Reviews of Treatments for Cirrhosis of the Liver

Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for cirrhosis of the liver.
Reviewed April 2012

Printer friendly page Printer friendly page

17 Resources Found

Results 1 to 17 displayed.

Title:   Hormone replacement for osteoporosis in women with primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Patients with primary biliary cirrhosis are mainly elderly women who are naturally prone to osteoporosis. Hormone replacement has been used worldwide to treat symptoms of menopause and to prevent chronic conditions such as osteoporosis. However, hormone...
Date:   Nov 2011
Title:   Bisphosphonates for osteoporosis in primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Primary biliary cirrhosis is an autoimmune disease of the liver that primarily affects middle-aged women and is associated with osteoporosis. Low bone mass is an important cause of morbidity in patients with primary biliary cirrhosis, leading to an incr...
Date:   Nov 2011
Title:   Prostaglandins for liver transplanted patients
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Liver transplantation is the most effective treatment for patients with advanced liver disease (cirrhosis). However, early postoperative problems such as graft failure or acute renal failure requiring dialysis are common. Patients evolving with such pro...
Date:   Aug 2011
Title:   Antibiotic prophylaxis for prevention of bacterial infections and death in cirrhotic patients with upper gastrointestinal bleeding
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Patients with liver cirrhosis have an impaired immune response. Often, liver cirrhosis patients experience complications from portal hypertension, such as gastroesophageal varices. These varices can bleed, increasing the risk of infection and death in a...
Date:   Jun 2010
Title:   Methotrexate for patients with primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Primary biliary cirrhosis is an uncommon chronic liver disease of unknown aetiology, affecting mostly women. It is characterised by progressive inflammation and destruction of the liver tissue, eventually progressing to liver cirrhosis and the need for ...
Date:   Apr 2010
Title:   Emergency sclerotherapy is not better than pharmacological therapy for acute variceal bleeding in cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Variceal bleeding in cirrhosis is associated with a high risk of death. Although banding ligation of varices is considered the choice for endoscopic treatment, emergency sclerotherapy is frequently used particularly where ligation is not available or wh...
Date:   Jan 2010
Title:   Existing trials, of poor quality, indicate that antibiotic prophylaxis reduces spontaneous bacterial peritonitis among cirrhotic patients with ascites and no gastrointestinal bleeding
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Spontaneous bacterial peritonitis (infection and inflammation of the membrane lining the abdominal cavity) is a frequent complication among cirrhotic patients (patients with end-stage liver disease marked by irreversible scarring of liver tissue) and is...
Date:   Feb 2009
Title:   Evidence to establish the beneficial and harmful effects of antacids for preventing oesophagogastric variceal bleeding and bleeding in cirrhotic patients is lacking
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Randomised trials with antacids for preventing oesophagogastric variceal bleeding and bleeding in cirrhotic patients could not be found. Valid evidence for or against the use of antacids for preventing oesophagogastric variceal bleeding and bleeding in ...
Date:   Feb 2008
Title:   Ursodeoxycholic acid is not likely to yield a benefit on survival of patients with primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Primary biliary cirrhosis is an uncommon and slowly progressive autoimmune disease of the liver that primarily attacks middle-aged women. The cause of the disease is unknown. Over the last 30 years, substantial increases in the prevalence of primary bil...
Date:   Jan 2008
Title:   Cyclosporin A was without significant effects on mortality, liver transplantation, or progression of primary biliary cirrhosis, and patients given cyclosporin A experienced more adverse events
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Primary biliary cirrhosis (PBC) is a chronic disease of the liver that is characterised by destruction of bile ducts. Estimates of annual incidence range from 2 to 24 people per million population, and estimates of prevalence range from 19 to 240 people...
Date:   May 2007
Title:   There is no evidence to support azathioprine for patients with primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Primary biliary cirrhosis (PBC) is a chronic disease of the liver that is characterised by destruction of bile ducts. Estimates of annual incidence range from 2 to 24 patients per million population, and estimates of prevalence range from 19 to 240 pati...
Date:   May 2007
Title:   Patients with refractory ascites may temporarily benefit from transjugular intrahepatic portosystemic stent-shunts
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Refractory ascites causes substantial morbidity in patients with cirrhosis. Randomised trials have compared transjugular intrahepatic portosystemic stent-shunts with paracentesis. Mortality, gastrointestinal bleeding, renal failure, or infection did not...
Date:   Aug 2006
Title:   Portosystemic shunts compared with sclerotherapy/banding lowers variceal rebleeding, but increases hepatic encephalopathy
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   A third of deaths from cirrhosis are due to variceal bleeding. Randomised clinical trials have compared three types of portosystemic shunting separately against endoscopic therapy. The shunts included in these trials have been total portocaval shunts, d...
Date:   Aug 2006
Title:   Evidence supporting colchicine for alcoholic, viral, and cryptogenic liver fibrosis/cirrhosis is still lacking
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Alcohol and hepatotropic viruses are major causes of liver fibrosis and liver cirrhosis. Colchicine is an anti-inflammatory and anti-fibrotic drug. This systematic review could not demonstrate any significant beneficial effects of colchicine on mortalit...
Date:   Feb 2005
Title:   No evidence to support or refute glucocorticosteroids for patients with primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Primary biliary cirrhosis is a chronic progressive cholestatic liver disease of presumed autoimmune aetiology. The clinical course might be improved by glucocorticosteroids. Only two small randomised clinical trials on this topic were identified. The tr...
Date:   Feb 2005
Title:   No convincing evidence either to support or refute the use of colchicine for patients with primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Primary biliary cirrhosis is a rare, chronic liver disease of unknown etiology. Colchicine, a plant alkaloid, has been used to treat patients with primary biliary cirrhosis and was tested in randomised clinical trials. When all identified trials were co...
Date:   Feb 2004
Title:   Terlipressin is a safe and effective treatment for bleeding from oesophageal varices which is a life threatening complication of cirrhosis of the liver
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Esophageal varices are abnormal dilatations of veins in the lower part of the swallowing tube (oesophagus) that may develop in patients with chronic liver damage (cirrhosis). Bleeding from these varices is a life threatening complication with mortality ...
Date:   Oct 2002

Results 1 to 17 displayed.